Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

7.90
+0.03000.38%
Post-market: 8.020.1200+1.52%18:47 EDT
Volume:441.38K
Turnover:3.49M
Market Cap:2.46B
PE:36.32
High:8.01
Open:7.82
Low:7.79
Close:7.87
52wk High:13.70
52wk Low:7.35
Shares:311.60M
Float Shares:116.17M
Volume Ratio:1.20
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2175
EPS(LYR):-0.8654
ROE:--
ROA:2.83%
PB:-14.20
PE(LYR):-9.13

Loading ...

European Medicines Agency Recommends Marketing Approval for Alvotech's Biosimilar Gobivaz®, with Advanz Pharma Set to Commercialize in Europe

Reuters
·
Sep 22

European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (Golimumab) With Advanz Pharma as Commercialization Partner

THOMSON REUTERS
·
Sep 22

Alvotech Sa - Announces Approval for Three Biosimilars in Japan

THOMSON REUTERS
·
Sep 19

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars

GlobeNewswire
·
Sep 19

Alvotech SA to Participate in Morgan Stanley Global Healthcare Conference in New York

Reuters
·
Sep 04

Alvotech Says European Commission Approved Mynzepli to Treat Retinal Diseases

MT Newswires Live
·
Aug 21

European Commission Approves Alvotech's Mynzepli® as Biosimilar to Eylea® for Retinal Diseases Across EEA Member Countries

Reuters
·
Aug 21

Advanz Pharma and Alvotech Receive European Approval for Mynzepli®, Biosimilar to Eylea®

THOMSON REUTERS
·
Aug 21

Alvotech SA Appoints Patrik Ling as VP of Investor Relations for Scandinavia, Strengthening Presence in Nordic Life-Science Sector

Reuters
·
Aug 20

Stock Track | Alvotech Soars 5.92% After-Hours Following Analyst's Bullish Stance

Stock Track
·
Aug 16

BRIEF-Alvotech H1 Operating Income USD 28.639 Million

Reuters
·
Aug 14

Alvotech Swings to Profit in H1, Product Revenue Rises; Shares Gain After Hours

MT Newswires Live
·
Aug 14

Stock Track | Alvotech Shares Surge 9.15% After-Hours on Strong H1 2025 Results, Reporting 200% Revenue Growth

Stock Track
·
Aug 14

Stock Track | Alvotech Soars 9.15% After-Hours on Strong H1 2025 Results, 200% Revenue Growth

Stock Track
·
Aug 14

Alvotech H1 EPS $0.49 Up From $(0.61) YoY; Revenue $204.7M Up From $65.9M YoY

Benzinga
·
Aug 14

Alvotech SA Releases Q2 2025 MD&A Report

Reuters
·
Aug 14

Alvotech Reports $141.7M Net Profit and Over 200% Growth in Product Revenues for First Half of 2025

Reuters
·
Aug 14

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

GlobeNewswire
·
Aug 14

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

GlobeNewswire
·
Aug 06

Alvotech SA Announces Amendment to Term Loan Credit Agreement for M&A Transaction Update

Reuters
·
Jul 29